Ascend Capital’s Ambev ABEV Stock Holding History

Ascend Capital’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1,938,031	Closed	-$14.2M	–	181
2013 Q4	$14.2M	Buy	+1,938,031	New	+$14.2M	0.43%	80

Other funds holding ABEV

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

GTP

Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ascend Capital's ABEV Position: Q1 2014 in Review

Ascend Capital sold out of Ambev (ABEV) in Q1 2014, closing a stake of 1,938,031 shares — an estimated $14.2M sold.

Ascend Capital first reported a position in ABEV in Q4 2013 and held it in 1 quarter. The position peaked at $14.2M in Q4 2013. 313 funds tracked by Wall St. Rank hold ABEV as of Q1 2014.

Ascend Capital reported no remaining Ambev position as of Q1 2014 after selling out during the quarter.
Ascend Capital sold 1,938,031 Ambev shares in Q1 2014, an estimated $14.2M.
Ascend Capital first reported a position in Ambev in Q4 2013 and held it in 1 quarter.
Ascend Capital's Ambev position peaked at $14.2M in Q4 2013.
313 funds tracked by Wall St. Rank held Ambev as of Q1 2014.

Based on Ascend Capital's 13F filing for Q1 2014, filed 14 May 2014.